Tudóstér: Koncz Gábor publikációi

Jenei, V., Burai, S., Molnár, T., Kardos, B., Mácsik, R., Tóth, M., Debreceni, Z., Bácsi, A., Türk-Mázló, A., Koncz, G.: Comparison of the immunomodulatory potential of platinum-based anti-cancer drugs and anthracyclins on human monocyte-derived cells.
Cancer Chemother. Pharmacol. 91 (1), 53-66, 2023.

Koncz, G., Jenei, V., Tóth, M., Váradi, E., Kardos, B., Bácsi, A., Türk-Mázló, A.: Damage-mediated macrophage polarization in sterile inflammation.
Front. Immunol. 14 1-18, 2023.

Burai, S., Kovács, R., Molnár, T., Tóth, M., Szendi-Szatmári, T., Jenei, V., Bíró-Debreceni, Z., Brisco, S., Balázs, M., Bácsi, A., Koncz, G., Türk-Mázló, A.: Comprehensive analysis of different tumor cell-line produced soluble mediators on the differentiation and functional properties of monocyte-derived dendritic cells.
PLoS One. 17 (10), 1-23, 2022.

Türk-Mázló, A., Tang, Y., Jenei, V., Brauman, J., Mustafa, H., Bácsi, A., Koncz, G.: Resolution Potential of Necrotic Cell Death Pathways.
Int. J. Mol. Sci. 24 (1), 1-24, 2022.

Türk-Mázló, A., Jenei, V., Burai, S., Molnár, T., Bácsi, A., Koncz, G.: Types of necroinflammation, the effect of cell death modalities on sterile inflammation.
Cell Death Dis. 13 (5), 1-12, 2022.

Prechl, J., Szöllősi, A., Koncz, G.: A SARS-CoV-2 aktivált adaptív immunválasz és a vakcinációindukált védelem komponensei.
Immunol. Szle. 13 (4), 22-30, 2021.

Molnár, T., Pallagi, P., Tél, B., Király, R., Csoma, E., Jenei, V., Varga, Z., Gogolák, P., Odile Hueber, A., Máté, Z., Erdélyi, F., Szabó, G., Pettkó-Szandtner, A., Bácsi, A., Virág, L., Maléth, J., Koncz, G.: Caspase-9 acts as a regulator of necroptotic cell death.
FEBS J. 288 (22), 6476-6491, 2021.

Varga, Z., Rácz, E., Türk-Mázló, A., Korodi, M., Szabó, A., Molnár, T., Szöőr, Á., Veréb, Z., Bácsi, A., Koncz, G.: Cytotoxic activity of human dendritic cells induces RIPK1-dependent cell death.
Immunobiology. 226 (1), 1-7, 2021.

Bugya, Z., Prechl, J., Szénási, T., Nemes, É., Bácsi, A., Koncz, G.: Multiple Levels of Immunological Memory and Their Association with Vaccination.
Vaccines. 9 (2), 174-, 2021.

Varga, Z., Molnár, T., Türk-Mázló, A., Kovács, R., Jenei, V., Kerekes, K., Bácsi, A., Koncz, G.: Differences in the sensitivity of classically and alternatively activated macrophages to TAK1 inhibitor-induced necroptosis.
Cancer Immunol. Immunother. 8 1-15, 2020.

Veréb, Z., Türk-Mázló, A., Szabó, A., Póliska, S., Kiss, A., Litauszky, K., Koncz, G., Boda, Z., Rajnavölgyi, É., Bácsi, A.: Vessel Wall-Derived Mesenchymal Stromal Cells Share Similar Differentiation Potential and Immunomodulatory Properties with Bone Marrow-Derived Stromal Cells.
Stem Cells International. 2020 1-16, 2020.

Molnár, T., Türk-Mázló, A., Tslaf, V., Szöllősi, A., Emri, G., Koncz, G.: Current translational potential and underlying molecular mechanisms of necroptosis.
Cell Death Dis. 10 (11), 1-21, 2019.

Hancz, D., Szabó, A., Molnár, T., Varga, Z., Hancz, A., Gregus, A., Hueber, A., Rajnavölgyi, É., Koncz, G.: Flagellin increases death receptor-mediated cell death in a RIP1-dependent manner.
Immunol. Lett. 193 42-50, 2018.

Szabó, A., Gogolák, P., Koncz, G., Földvári, Z., Pázmándi, K., Miltner, N., Póliska, S., Bácsi, A., Djurovic, S., Rajnavölgyi, É.: Immunomodulatory capacity of the serotonin receptor 5-HT2B in a subset of human dendritic cells.
Sci Rep. 8 1-12, 2018.

Hornyák, L., Dobos, N., Koncz, G., Karányi, Z., Páll, D., Szabó, Z., Halmos, G., Székvölgyi, L.: The role of indoleamine-2,3-dioxygenase (IDO) in cancer development, diagnostics, and therapy.
Front. Immunol. 9 (151), 1-8, 2018.

Emri, G., Paragh, G., Tósaki, Á., Janka, E., Kollár, S., Hegedűs, C., Gellén, E., Horkay, I., Koncz, G., Remenyik, É.: Ultraviolet radiation-mediated development of cutaneous melanoma: an update.
J. Photochem. Photobiol. B-Biol. 185 169-175, 2018.

Fekete, T., Koncz, G., Szabó, B., Gregus, A., Rajnavölgyi, É.: Interferon gamma boosts the nucleotide oligomerization domain 2-mediated signaling pathway in human dendritic cells in an X-linked inhibitor of apoptosis protein and mammalian target of rapamycin-dependent manner.
Cell. Mol. Immunol. 14 (4), 380-391, 2017.

Szabó, A., Fekete, T., Koncz, G., Kumar, B., Pázmándi, K., Földvári, Z., Hegedűs, B., Garay, T., Bácsi, A., Rajnavölgyi, É., Lányi, Á.: RIG-I inhibits the MAPK-dependent proliferation of BRAF mutant melanoma cells via MKP-1.
Cell. Signal. 28 (5), 335-347, 2016.

Fekete, T., Pázmándi, K., Szabó, A., Bácsi, A., Koncz, G., Rajnavölgyi, É.: The antiviral immune response in human conventional dendritic cells is controlled by the mammalian target of rapamycin.
J. Leukoc. Biol. 96 1-11, 2014.

Kovács, E., Szilágyi, L., Koncz, G., Lányi, S., Ábrahám, B.: Enhanced in vitro refolding of soluble human glucocorticoid-induced TNF receptor-related ligand.
Appl. Biochem. Biotechnol. 170 (4), 819-830, 2013.

Koncz, G., Hueber, A.: The Fas/CD95 Receptor Regulates the Death of Autoreactive B Cells and the Selection of Antigen-Specific B Cells.
Front. Immunol. 3 1-12, 2012.

Hancz, A., Koncz, G., Szili, D., Sármay, G.: TLR9-mediated signals rescue B-cells from Fas-induced apoptosis via inactivation of caspases.
Immunol. Lett. 143 (1), 77-84, 2012.

Koncz, G., Hancz, A., Chakrabandhu, K., Gogolák, P., Kerekes, K., Rajnavölgyi, É., Hueber, A.: Vesicles Released by Activated T Cells Induce Both Fas-Mediated RIP-Dependent Apoptotic and Fas-Independent Nonapoptotic Cell Deaths.
J. Immunol. 189 (6), 2815-2823, 2012.

Koncz, G., Papp, M., Török, P., Kotroczó, Z., Krakomperger, Z., Matus, G.: Egy cseres-tölgyes állomány (Síkfőkút, Bükk-hegység) magbankja és szerepe a lágyszárú szint regenerálódásában.
Termvéd. közl. 15 304-315, 2009.

Papp, M., Koncz, G., Kotroczó, Z., Krakomperger, Z., Schellenberger, J., Tóth, J.: Egy cseres-tölgyes lágyszárú növényzetének válasza avarmanipulációra.
Termvéd. közl. 15 316-327, 2009.

Maus, M., Medgyesi, D., Kövesdi, D., Csuka, D., Koncz, G., Sármay, G.: Grb2 associated binder 2 couples B-cell receptor to cell survival.
Cell. Signal. 21 (2), 220-227, 2009.

Hancz, A., Hérincs, Z., Neer, Z., Sármay, G., Koncz, G.: Integration of signals mediated by B-cell receptor, B-cell activating factor of the tumor necrosis factor family (BAFF) and Fas (CD95).
Immunol. Lett. 116 (2), 211-217, 2008.

Koncz, G., Kerekes, K., Chakrabandhu, K., Hueber, A.: Regulating Vav1 phosphorylation by the SHP-1 tyrosine phosphatase is a fine-tuning mechanism for the negative regulation of DISC formation and Fas-mediated cell death signaling.
Cell Death Differ. 15 (3), 494-503, 2008.

Medgyesi, D., Sárközi, R., Koncz, G., Arató, K., Váradi, G., Tóth, G., Sármay, G.: Functional consequences of a MAPK docking site on human FcγRIIb.
Immunol. Lett. 92 (1-2), 83-90, 2004.

Medgyesi, D., Uray, K., Sallai, K., Hudecz, F., Koncz, G., Abramson, J., Pecht, I., Sármay, G., Gergely, J.: Functional mapping of the FcγRII binding site on human IgG1 by synthetic peptides.
Eur. J. Immunol. 34 (4), 1127-1135, 2004.

Koncz, G., Bodor, C., Kövesdi, D., Gáti, R., Sármay, G.: BCR mediated signal transduction in immature and mature B cells.
Immunol. Lett. 82 (1-2), 41-49, 2002.

Kövesdi, D., Koncz, G., Iványi-Nagy, R., Caspi, Y., Ishiai, M., Kurosaki, T., Gergely, J., Haimovich, J., Sármay, G.: Developmental differences in B cell receptor-induced signal transduction.
Cell. Signal. 14 (6), 563-572, 2002.

Sármay, G., Koncz, G., Bodor, C., Kövesdi, D., Gáti, R., Gergely, J.: Signaling pathways leading to apoptosis or survival in immature and mature B cells.
Ann. N. Y. Acad. Sci. 973 181-185, 2002.

Koncz, G., Tóth, G., Bökönyi, G., Kéri, G., Pecht, I., Medgyesi, D., Gergely, J., Sármay, G.: Co-clustering of Fcγ and B cell receptors induces dephosphorylation of the Grb2-associated binder 1 docking protein.
Eur. J. Biochem. 268 (14), 3898-3906, 2001.

Kurucz, I., Hilbert, Á., Kapus, A., Medgyesi, D., Koncz, G., Sármay, G., Erdei, A., Gergely, J.: Bacterially expressed human FcγRIIb is soluble and functionally active after in vitro refolding.
Immunol. Lett. 75 (1), 33-40, 2000.

Sármay, G., Koncz, G., Pecht, I., Gergely, J.: Cooperation between SHP-2, phosphatidyl inositol 3-kinase and phosphoinositol 5-phosphatase in the FcγRIIb mediated B cell regulation.
Immunol. Lett. 68 (1), 25-34, 1999.

Koncz, G., Pecht, I., Gergely, J., Sármay, G.: Fcγ receptor-mediated inhibition of human B cell activation: the role of SHP-2 phosphatase.
Eur. J. Immunol. 29 (6), 1980-1989, 1999.

Koncz, G., Gergely, J., Sármay, G.: FcγRIIb inhibits both B cell receptor- and CD19-induced Ca2+ mobilization in FcγR-transfected human B cells.
Int. Immunol. 10 (2), 141-146, 1998.

Sármay, G., Koncz, G., Pecht, I., Gergely, J.: Fcγ receptor type IIb induced recruitment of inositol and protein phosphatases to the signal transductory complex of human B-cell.
Immunol. Lett. 57 (1-3), 159-164, 1997.

Káldi, K., Szászi, K., Koncz, G., Suszták, K., Ligeti, E.: Arachidonic acid activatable electrogenic H+ transport in the absence of cytochrome b558 in human T lymphocytes.
FEBS Lett. 381 (1-2), 156-160, 1996.

Sármay, G., Koncz, G., Gergely, J.: Human Type II Fcγ Receptors Inhibit B Cell Activation by Interacting with the p21ras-dependent Pathway.
J. Biol. Chem. 271 (48), 30499-30504, 1996.

Sármay, G., Koncz, G., Gergely, J.: Integration of activatory and inhibitory signals in human B-cells.
Immunol. Lett. 54 (2-3), 93-100, 1996.

Sármay, G., Rozsnyay, Z., Koncz, G., Gergely, J.: Interaction of signaling molecules with human FcγRIIb1 and the role of various FcγRIIb isoforms in B-cell regulation.
Immunol. Lett. 44 (2-3), 125-131, 1995.

Sármay, G., Rozsnyay, Z., Koncz, G., Danilkovich, A., Gergely, J.: The alternative splicing of human FcγRII mRNA is regulated by activation of B cells with mIgM cross-linking, interleukin-4, or phorbolester.
Eur. J. Immunol. 25 (1), 262-268, 1995.